The D+Q protocol combining dasatinib and quercetin is the most researched senolytic approach. Here is the evidence, how it works, and the role quercetin plays.
When researchers at the Mayo Clinic set out to find drugs that could selectively eliminate aging zombie cells, they screened hundreds of compounds. The winner was not a single drug but a combination: dasatinib and quercetin (D+Q). This two-drug protocol has since become the gold standard in senolytic research, with multiple human clinical trials demonstrating measurable zombie cell clearance in actual patients.
Understanding the D+Q protocol matters even if you never take dasatinib yourself — because quercetin, the accessible half of this combination, is available over the counter. And the principles behind D+Q inform how natural senolytics like fisetin and quercetin should be used. For the broader context on zombie cells, see our senescent cells explainer.
> - Compounds: Dasatinib (prescription) + Quercetin (OTC)
> - Research Dose: Dasatinib 100 mg + Quercetin 1,000 mg
> - Duration: 3 consecutive days per cycle
> - Frequency: Monthly or as prescribed
> - Status: Multiple human clinical trials completed/ongoing
> - Quercetin Component: Quercetin Phytosome — 500 mg twice daily for 2 consecutive days
The D+Q story begins with James Kirkland, MD, PhD, a gerontologist at the Mayo Clinic who hypothesized that if you could safely clear senescent cells from aged tissues, you could slow or reverse aspects of biological aging. His team systematically screened compounds for senolytic activity — the ability to kill senescent cells while leaving healthy cells unharmed.
They found that no single compound was broadly effective against all types of senescent cells. Different tissues produce senescent cells with different survival strategies. But by combining two drugs with complementary mechanisms, they achieved comprehensive clearance:
Dasatinib — originally developed as a cancer drug (a tyrosine kinase inhibitor used for chronic myeloid leukemia). It targets the pro-survival networks that certain senescent cells use, particularly in fat tissue and the cardiovascular system.
Quercetin — a natural flavonoid found in onions and apples. It targets different anti-apoptotic pathways, particularly BCL-2 family proteins and serpine1/PAI-1, which are upregulated in senescent cells in endothelial tissue and bone marrow stem cells.
Together, they cover more ground than either alone. This synergistic principle is why many natural senolytic protocols now combine fisetin and quercetin — mimicking the dual-mechanism logic of D+Q.
What separates D+Q from most longevity interventions is that it has been tested in actual human clinical trials, not just mice and cell cultures:
Senescent cells survive because they upregulate anti-apoptotic pathways — molecular mechanisms that prevent cell death. Think of these as shields protecting the zombie cell from the death signals it should be responding to.
Dasatinib inhibits multiple tyrosine kinases that senescent cells depend on:
Quercetin hits different targets:
No single compound eliminates all senescent cells because different tissues have senescent cells with different vulnerabilities. The D+Q combination achieves broader coverage — exactly the same logic behind combining fisetin and quercetin for an over-the-counter protocol.
Dasatinib is a powerful pharmaceutical with a significant side effect profile:
This is precisely why quercetin matters so much. It is the accessible, over-the-counter component of the most proven senolytic protocol.
For most people reading this, the practical question is: how effective is quercetin alone as a senolytic?
The honest answer: Less effective than the full D+Q combination, but still potentially valuable.
Quercetin alone targets BCL-2 family proteins and serpine1, which are present in many senescent cell types. High-dose intermittent quercetin (1,000–1,500 mg for 2–3 days monthly) may clear a subset of senescent cells that depend on these specific pathways.
Enhancing quercetin's senolytic activity:
For those wanting maximum natural senolytic coverage, the fisetin + quercetin combination is the closest over-the-counter analog to D+Q. See our best senolytic supplements guide.
We strongly advise against this. Dasatinib is a potent pharmaceutical with real risks. Purchasing from unregulated sources raises additional concerns about purity and dosing accuracy. If you are interested in the D+Q protocol, discuss it with a physician knowledgeable in longevity medicine.
Probably not as potent, based on current evidence. D+Q has human clinical trial data showing measurable senescent cell clearance. Fisetin + quercetin has strong preclinical rationale but less direct human evidence for the combination. However, it is the best available over-the-counter alternative.
In clinical trials, D+Q has been given for 3 consecutive days per cycle, repeated either weekly for short courses or monthly for ongoing management. The exact frequency likely depends on the condition being treated and individual response.
Daily low-dose quercetin provides excellent antioxidant and anti-inflammatory benefits, but likely does not reach the tissue concentrations needed for senolytic activity. The hit-and-run pulse approach — high doses for 2–3 days — is specifically designed to overwhelm senescent cell survival mechanisms. See our fisetin dosage protocol guide for details.
Yes. Navitoclax (ABT-263) is a more targeted BCL-2 inhibitor with potent senolytic activity but significant side effects (particularly low platelet counts). Several biotech companies are developing next-generation senolytics with better specificity and fewer side effects. These are in early clinical stages.
This is the expectation of most aging researchers. If ongoing clinical trials demonstrate clear benefits with acceptable safety in diseases of aging, senolytics could become a routine part of geriatric medicine within the next decade. For now, quercetin and fisetin represent the accessible frontier.
The D+Q protocol represents the most scientifically validated senolytic approach available today, with actual human clinical trial data showing zombie cell clearance. While dasatinib requires medical supervision, quercetin is the accessible component you can start using now. For maximum benefit, consider combining quercetin phytosome with fisetin using the intermittent pulse protocol — the closest over-the-counter equivalent to the gold-standard D+Q approach.
*Affiliate links from Amazon — we may earn a small commission at no extra cost to you.*